Danaher reported its third-quarter 2021 revenue at $7.2 billion, a 23% increase over the same period last year.
Latest In Danaher
The manufacturer reported a strong second quarter, as profit almost doubled to $1.7 billion.
Newly appointed EVP Jennifer L. Honeycutt will be responsible for a handful of Danaher's business divisions.
As part of the company’s previously disclosed succession plan, Blair is replacing retiring CEO Thomas P. Joyce Jr.
Company reports solid results; earnings rise 15 percent to $663.7 million.
Manufacturer reports strong second quarter, as earnings rise 20 percent.
IDT develops, manufactures and markets nucleic acid products.
Danaher names Matthew McGrew to succeed Daniel Comas as CFO.
Year-to-date, the manufacturer reported sales of $13.2 billion, up 7.3 percent.
Rainer Blair promoted to position.
For the first nine months, sales were up 21.6 percent year-over-year.
Cepheid will become part of the company's diagnostics segment.